External sonication

Through external sonication technology and the use of sonication particles, the existing sonication system's problems in sample damage and heat generation are solved, and efficient and accurate blood sample analysis is achieved.

CN114008451BActive Publication Date: 2024-11-01HEMEX HEALTH INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202080047343.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2019-06-25
Filing Date
2020-06-25
Publication Date
2024-11-01
Estimated Expiration
2040-06-25

AI Technical Summary

Technical Problem

Existing ultrasonic systems are prone to damage the samples when processing blood samples, resulting in heat generation and contamination, and it is difficult to effectively cleave the samples, affecting the diagnostic results.

Method used

Using external sonication technology, ultrasonic energy is transferred through the box wall to maximize the damage to the sample contents, while optimizing energy transfer, reducing heat generation and energy dissipation, sonicating particles and reagents are used to control the difficulty of destroying components and residual bubbles.

Benefits of technology

Effective damage and analysis of samples are achieved, opacity is reduced, heat generation and energy loss is reduced, and diagnostic accuracy and efficiency are improved.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN114008451B_ABST
    Figure CN114008451B_ABST
Patent Text Reader

Abstract

External sonication is a technique in which ultrasonic energy is applied externally to a cartridge containing a sample. External sonication can be performed by an ultrasonic generator located outside the sample in the cartridge. The cartridge can include sonication particles to enhance sonication or cavitation within the sample. Sonication algorithms can also be used to increase sonication efficiency.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS

[0002] This application claims the benefit of pending U.S. Provisional Patent Application No. 62 / 866,468, filed on June 25, 2019, the entire contents of which are incorporated herein by reference. Background Art

[0003] Patient diagnostic services save lives, shorten patient treatment time, and provide valuable insights for targeted treatment. In many developed countries, modern medical facilities can provide patients with state-of-the-art diagnostic services, allowing patients to receive efficient and effective treatment. In less developed countries or regions, often due to economic and infrastructure considerations, there may be a lack of high-quality medical facilities and diagnostic services. In many less developed countries, the economy cannot afford the latest medical technology and infrastructure required to support the high demand for modern medical technology, such as a strong power grid or well-trained clinicians. Sadly, a large portion of the world's population lives in underserved or underdeveloped areas, where the lack of efficient and effective diagnostic services seriously affects population morbidity, mortality, and overall health. Lack of medical services can cause or contribute to chain reactions, such as slow economic and educational development.

[0004] Often, many less developed countries and regions also lack sufficient trained users who are often required to perform the necessary diagnostic services. This can result in diagnostic services producing inconclusive or erroneous results, or in significant delays in diagnosis because the diagnostic service needs to be performed in another location that has the infrastructure and / or knowledge to perform the diagnostic service. For patients, this can mean increased time and transportation costs, leading to further delays in treatment, thereby reducing their chances of survival, increasing the spread of disease, and / or leading to increased levels of frailty caused by the disease or condition.

[0005] Where large laboratories may be expensive and difficult to staff, diagnostic devices may offer an effective solution that can deliver timely, accurate, and cost-effective healthcare.

[0006] One of the common treatable diseases that affects less developed countries is hemoglobin disorders such as sickle cell disease (SCD), thalassemia, and other hemoglobinopathies. These are genetic diseases that are thought to have evolved in response to malaria. With population migration, these conditions have spread to the global population and are affecting the livelihoods and health of many people. With early detection or diagnosis, these diseases can be treated and managed before they have significant adverse effects on the patient. Like malaria, these disorders affect populations in less developed countries and regions that do not have access to diagnostic services that can quickly, effectively, and efficiently diagnose the disease.

[0007] These devices can perform diagnostic services or tests on blood samples. The blood sample may need to be processed in some manner so that the device can properly analyze the sample. For example, one or more components of the blood sample may need to be lysed to release components in the sample, to release a first component from a second component to analyze the first component, and so on.

[0008] Current sonication systems and methods for disrupting sample components include direct sonication (i.e., immersing an ultrasonic probe into the sample and contacting it) and wet sonication (i.e., placing the sample in a container and then partially immersing the container in an ultrasonic bath). Each implementation has its own disadvantages, some of which include sample size, lack of energy focus, potential contamination issues, overheating, etc. The volume or size of the sample directly affects the amount of ultrasonic energy required for complete disruption. Fluid viscosity also affects energy transfer - more viscous samples require more ultrasonic energy, which results in the generation of heat. Excessive heat generated can damage or destroy the sample being tested.

[0009] What is needed is a system or method for effectively lysing or disrupting sample lysis. BRIEF DESCRIPTION OF THE DRAWINGS

[0010] FIG1A shows the sample before sonication;

[0011] FIG1B shows the sample after sonication;

[0012] FIG2 is a block diagram of an example external ultrasonic generator system;

[0013] 3A to 3D show examples of probes;

[0014] FIG4 is a block diagram of an example external ultrasonic generator system;

[0015] FIG5 is a block diagram of an example driver program;

[0016] FIG6A shows an example of an out-of-phase waveform at a resonance point;

[0017] FIG6B shows an example of an in-phase waveform at a resonance point;

[0018] FIG7A shows an example of an undesirable sonication waveform;

[0019] FIG7B shows an example of a desired sonication waveform;

[0020] FIG8A shows an exploded view of an example cartridge;

[0021] FIG8B shows an example box;

[0022] FIG8C shows a cross-sectional view of an example cartridge. DETAILED DESCRIPTION

[0023] Sonication is the act of applying sound energy to agitate particles or components in a sample or culture medium. During sonication, the kinetic energy from the sound oscillations produced by the ultrasonic generator generates heat and cavitation bubbles. When this oscillating energy is effectively applied to the sample, the heat and / or cavitation bubbles (i.e., the formation and collapse of bubbles) agitate and disrupt the sample components. The volume or size of the sample directly affects the amount of ultrasonic energy required for complete disruption. Fluid viscosity also affects energy transfer - more viscous samples require more ultrasonic energy.

[0024] The blood sample may need to be processed in some manner so that the device can properly analyze the sample. The device can be used in a traditional laboratory setting, in the field (i.e., point of care), etc. The ultrasonic treatment can lyse a first component of the blood sample, thereby releasing a second component of the blood sample. For example, red blood cells can be lysed to release hemochrome. The blood sample with released hemochrome can be analyzed to determine the infection grade, infection type, etc., or combinations or multiples thereof.

[0025] Additionally, blood samples in a laboratory or lab-type setting may require processing for proper analysis. Sonication can be used to remove components (such as red blood cells) from blood samples without using reagents that may affect downstream results. For example, certain reagents can affect whole genome analysis, next generation sequencing, polymerase chain reaction, etc. Sonicating the sample to lyse the red blood cells, rather than using reagents to lyse the red blood cells, allows the sample to be properly analyzed in one or more downstream steps.

[0026] External sonication is a technique where ultrasonic energy is applied externally to a cartridge containing a sample. In one embodiment, the cartridge may be sealed or unsealed. The cartridge used may be commercially available or may be custom designed. External sonication is effective in maximizing disruption of sample contents while optimizing energy transfer into the sample, minimizing heat generation in the sample, and minimizing heat and energy dissipation into the sample.

[0027] The ultrasonic energy of the external ultrasonic treatment enters the sample through the box wall, thereby causing pressure changes, resulting in the generation and collapse of cavitation bubbles - the conversion of sound waves into mechanical energy. The mechanical energy dissipated into the sample results in effective sample content destruction without any ultrasonic probe in direct contact with the sample fluid. For example, effective external ultrasonic treatment can maximize the destruction of sample contents while optimizing energy transfer in the sample, minimizing heat generation in the sample, and minimizing heat and energy dissipation in the external ultrasonic treatment system. External ultrasonic treatment can be used for any appropriate sample. More specifically, some applications of external ultrasonic treatment include, but are not limited to, processing hazardous sample sources, destroying cells in closed systems to release viruses, DNA fragmentation, and heating / mixing / stirring solutions. In the following description, the term "resonance point" is used to describe a point or position on or within a system, or a point or position on or within a component of a system, which resonates. Resonance can be a resonant frequency. Resonance can be electrical or mechanical. For example, in mechanical resonance, when the ultrasonic generator applies oscillations at a frequency that matches the natural frequency of the component, the component of the blood sample absorbs more energy from the ultrasonic generator (such as an external ultrasonic generator).

[0028] In the following description, the term "sample" is used to describe at least one material to be tested, processed, combinations thereof, and the like. The sample can be inorganic, plant-based, organic-based, or animal-based. For example, the sample can be obtained or acquired from a plant, algae, mineral, and the like. As another example, the sample (e.g., a sample obtained or acquired from an organism, an animal, or a human) can be a biological fluid, a biological semisolid, a biological solid that can be liquefied in any appropriate manner, a suspension, a portion of a suspension, a component of a suspension, and the like. For convenience, reference is made to the sample as whole blood, but it is understood that the methods and systems described and discussed herein are used for any appropriate sample, such as urine, blood, bone marrow, buffy coat, cystic fluid, ascites, feces, semen, cerebrospinal fluid, nipple aspirate, saliva, amniotic fluid, mucosal secretions, aqueous humor, vitreous humor, vomitus, vaginal fluid, and any other physiological fluid or semisolid. For example, the sample is a tissue sample or material derived from adipose tissue, adrenal gland, bone marrow, breast, caudate nucleus, cerebellum, cerebral cortex, cervix, uterus, colon, endometrium, esophagus, fallopian tube, myocardium, hippocampus, hypothalamus, kidney, liver, lung, lymph node, ovary, pancreas, pituitary gland, prostate, salivary gland, skeletal muscle, skin, small intestine, large intestine, spleen, stomach, testicle, thyroid gland, or bladder.

[0029] In the following description, the term "ultrasonic particles" is used to describe an object or entity that increases or enhances the ultrasonic treatment, cavitation, or both of a sample by an external ultrasonic system. The ultrasonic particles can be beads, rods, nanoparticles, microspheres, etc. The ultrasonic particles can be composed of metals, silica, glass, polymers, etc., or a combination or composite thereof. When a plurality of ultrasonic particles are used, the ultrasonic particles can have the same characteristics, or at least two ultrasonic particles can have one or more different characteristics (e.g., size, shape, material, surface functionalization, surface depressions or indentations, etc.).

[0030] FIG. 1A shows a sample before external sonication (i.e., the blood cells of the sample are intact). FIG. 1B shows a sample after external sonication. As shown in FIG. 1B , external sonication reduces the opacity of the sample. While external sonication can reduce the opacity of blood, the opacity of other types of patient samples can remain unchanged or increase.

[0031] External sonication disrupts the blood cells of the sample, thereby causing the release of cellular contents including malarial parasites into the sample medium by disrupting or lysing the blood cell membranes. The malarial parasites are also disrupted, resulting in the release of parasite food vacuoles into the sample medium; these food vacuoles are subsequently disrupted, resulting in the release of aggregated crystals of hemochrome; and the aggregated crystals are disrupted by breaking lipid bonds, resulting in fewer crystal aggregates and the release of individual crystals into the sample medium.

[0032] The effectiveness of external sonication can be further enhanced by optimizing the efficiency of ultrasonic energy delivery (e.g., frequency, resonance point of the external ultrasonic generator system, amount of energy that can be delivered, temperature, amount of time that energy is delivered; by controlling or adjusting the sample volume, chemistry, or viscosity, such as by adding reagents (e.g., deionized water, detergents, surfactants, defoaming agents, colorants (e.g., fluorescent, colorimetric, etc.), etc.) to the sample to dilute the sample, change the difficulty of destroying components, or reduce residual bubbles within the sample; by adding additional materials, such as one or more sonication particles, the cavitation process can be initiated; by controlling the applied voltage of the ultrasonic transducer (fixed or variable); by controlling the current of the ultrasonic sensor (fixed or variable); by controlling the frequency of the ultrasonic transducer (fixed or variable); by controlling the on / off time of the voltage; by controlling the on / off time of the current; or by controlling the on / off time of the ultrasonic sensor (fixed or variable). In addition, the reagents can be used for downstream processing or compatible with further downstream processing. In one aspect, more effective external sonication allows for a reduction in the ultrasonic energy used to destroy the contents of the sample.

[0033] FIG2 shows a block diagram of the external ultrasonic generator system 200. First, a sample is provided in a cartridge 800. Before or after the sample is added to the cartridge 800, the sample may be treated, for example, by adding one or more reagents, including but not limited to magnetic nanoparticles, non-magnetic solids, surfactants, defoamers, penetrants, deionized water, diluents, detergents, alcohols (e.g., isopropyl alcohol), biocides,

[0034] Stains / labels, combinations thereof, etc.

[0035] The box 800 is then placed in contact with or inserted into the probe 202 of the ultrasonic generator 204. The ultrasonic generator 204 includes an ultrasonic transducer 206 that generates ultrasonic energy or ultrasonic sound waves and is connected to the probe 202, which transmits the ultrasonic energy or ultrasonic sound waves to the box 800. The ultrasonic energy or ultrasonic sound waves then enter the sample held in the box 800. In order to begin transferring ultrasonic energy into the box 800, the voltage applied to the ultrasonic transducer 206 varies at a fixed or random frequency around the resonance point of the external ultrasonic generator system 200. In one embodiment, the ultrasonic transducer 206 is connected to the probe 202 in a manner that does not inhibit the available energy for transfer or does not change the resonance point (e.g., reinforced connection, reinforced support, damper, combination thereof, etc.).

[0036] The design of the probe 202 focuses the energy transfer to and through the walls of the box 800. The design of the probe 202 also increases or decreases the energy transfer to and through the walls of the box 800. The design of the probe 202 can also be selected to maximize the contact area with the box 800. The design of the probe 202 transfers the ultrasonic energy to one or more surfaces of the box 800, or transfers the ultrasonic energy to multiple boxes (i.e., the probe 202 can work with multiple boxes, box shapes, box configurations, etc.).

[0037] The characteristics of the probe 202 (e.g., length, material, diameter, or both) may be selected to match the resonance point of the ultrasonic transducer. For example, the length of the probe 202 may be determined by the ultrasonic generator frequency. Longer probes produce longer wavelengths, which are inversely proportional to the frequency (i.e., frequency = 1 / wavelength). Therefore, the length of the probe 202 may be inversely proportional to or matched to the ultrasonic generator frequency (i.e., the probe 202 is shorter for higher frequencies).

[0038] Different materials have different resonance points. The resonance point of a material can be determined by the material density, elastic modulus, or both.

[0039] The shape, size, or contact area of ​​the probe 202 may be selected based on one or more features of the wall of the box 800 (e.g., material, thickness, shape, area, radius, curve, angle, combination thereof, etc.) to optimize or more effectively focus or disperse the ultrasonic energy to the sample. For example, a probe shaped to conform to the contour of the box, with more contact area and less air gap between the probe and the wall, may more effectively transfer ultrasonic energy than a probe with less contact area and more air gap with the wall of the box. As another example, a larger probe may have a larger surface area, thereby having more energy transfer than a smaller probe.

[0040] Fig. 3A-3B shows the probe example of insertable box.The size and shape of box can be suitable for the opening or the incision of probe.For example, probe comprises the piece 310 (Fig. 3A) with the I-shaped incision extending through it, and the piece 320 (Fig. 3B) with the tapered, V-shaped or bottle-shaped incision extending through it.A part of box can be tapered, so that it can be installed in the tapered incision, or a part of box can be rectangular, so that it can be installed in the middle part of the I-shaped incision.By putting the box into the incision or the opening of the probe, the box can be inserted in the probe.Perhaps, the incision or the opening of the probe can slide above the box or be placed on the box top.

[0041] 3C-3D show examples of probes that contact the outer surface of the box. The tip of the probe or one side of the probe can contact the outer wall of the box. Example probes include partially conical tips with flat or chisel-shaped faces 330 (FIG. 3C), rods or hemispherical shapes 340 (FIG. 3D).

[0042] 2, the ultrasonic generator 204 is controlled by a microcontroller 208, which is programmed to control one or more parameters of the external ultrasonic system 200 to produce effective content destruction of the sample in the cartridge 800, to determine how the sample changes before, during and after ultrasonic treatment, or to provide real-time control and feedback. In one embodiment, the microcontroller 208 is electrically connected to the ultrasonic transducer 206 of the ultrasonic generator 204. For example, the variable control allows automatic adjustment to adjust for potential drift of the control parameters during use and over time, which can affect the effectiveness of the destruction.

[0043] The microcontroller 208 controls one or more parameters of the external ultrasonic processing system 200 based on at least one of the position of the external ultrasonic generator relative to the box wall, the contact pressure of the probe, the sample ultrasonic processing feedback, the user input settings, and the manufacturing component feedback. The user input can be obtained via the user interface 212 to receive input such as instructions, sample information, patient information, etc., or output results, data, or other information. The user interface can be a display, such as a screen (such as a touch screen), a light, or other visual indicator. The touch screen for displaying information (such as analysis results) to the user can also be used by the user to input to the external ultrasonic processing system 200. The audio output may include a speaker, a buzzer, or other audio indicator. The visual and / or auditory output can be output through an external device, such as a computer, a speaker, or a mobile device that is physically or wirelessly connected to the external ultrasonic processing system 200. The user interface 212 may include tactile prompts, inputs, and outputs. Whether it is visual, auditory, or tactile output, data can be output, including collected analysis data and explanatory data indicating a diagnosis, including whether there is an infection, disease, or condition in a patient or patient sample. Examples may include whether there is hemochromatin in a patient sample. The interpreted data output may be based on analysis data collected and processed by processing circuitry of the external ultrasound system 200 .

[0044] Parameters controlled by the microcontroller 208 and component and sample feedback provided to the microcontroller 208 include, but are not limited to, voltage, current, frequency, position, probe position (e.g., contact or non-contact box), probe contact force, temperature, time, probe temperature, sound generation during external ultrasonic treatment, sample opacity, sample temperature, and sample agitation. The microcontroller 208 controls one or more parameters through hardware or software. The microcontroller 208 can apply parameters by maintaining a constant value (e.g., maintaining the same voltage or frequency), stepping, waveform, etc., or a combination or compound thereof. For example, the microcontroller 208 can control the temperature of the ultrasonic transducer, sample, or ultrasonic transducer and sample by reducing the voltage or current to the ultrasonic transducer 206 during external ultrasonic treatment; pulsing the voltage or current on and off to the ultrasonic transducer 206; or, running the ultrasonic transducer 206 until the temperature exceeds a hot threshold, then shutting off the voltage or current to the ultrasonic transducer 206 until the temperature reaches a cold threshold, and then repeating until the external ultrasonic treatment is completed. As another example, the microcontroller 208 controls the timing of the external sonication of the ultrasonic transducer through software or firmware to continue the sonication for an additional period of time or to interrupt the sonication for a shorter duration. Alternatively, although a microcontroller is discussed, the external ultrasonic generator system 200 may include one or more of a processor / microprocessor, memory, or programmable input / output peripherals.

[0045] The microcontroller 208 can also control the movement of the ultrasonic generator 204 along one or more axes via the motor 210. The motor 210 can be a servo motor, a stepper motor, an actuator (e.g., piezoelectric, electric, pneumatic, mechanical, linear or rotary), a solenoid, or any suitable device for providing movement along at least one axis. In one embodiment, the motor 210 is connected to a housing (not shown). In one embodiment, the motor 210 is connected to the ultrasonic transducer 206.

[0046] The ultrasonic generator 204 may also include a sensor 214 for determining the force applied to or on the probe 202 (e.g., based on contact with the cartridge), or determining the distance between the probe 202 and the cartridge 800 to avoid overtravel (i.e., moving beyond the desired contact point) or undertravel (i.e., not moving to the desired contact point). The sensor 214 may be mechanical (e.g., a switch), electrical (e.g., a linear encoder), capacitive, optical (e.g., a laser), acoustic, inductive (e.g., a linear variable differential transformer), etc.

[0047] FIG4 shows a block diagram of an external ultrasonic generator system 400. The external ultrasonic generator system 400 is similar to the external ultrasonic generator system 200, except that the external ultrasonic generator system 400 does not include any system or sample feedback. In one embodiment, the parameters of the external ultrasonic processing system 400 set and controlled by the microcontroller 208 are fixed (i.e., the parameters do not change). Fixed control does not take into account potential drift of the control parameters during use and over time, which can affect the effectiveness of destruction. In one embodiment, the parameters of the external ultrasonic processing system 400 set and controlled by the microcontroller 208 are variable (i.e., one or more parameters change). Variable control allows automatic adjustment to adjust for potential drift of the control parameters during use and over time, which can affect the effectiveness of destruction.

[0048] The external ultrasonic generator system 200, 400 can be used in any direction on the box, such as top ultrasonic treatment, bottom ultrasonic treatment, side ultrasonic treatment or a combination thereof. In addition, the external ultrasonic treatment system 200, 400 can include a probe contact control so that the external ultrasonic treatment system automatically turns on when the probe contacts the box and automatically turns off when the probe is no longer in contact with the box. Alternatively, the external ultrasonic treatment system can be turned on and off according to the force applied by the probe or the force applied on the probe.

[0049] The frequency can be adjusted manually or automatically, such as by closed-loop feedback. FIG. 5 shows an example driver 508 that includes a feedback loop for resonance compensation of the external ultrasonic generator system 500. The driver 508 defines the maximum power delivery for each ultrasonic treatment cycle and adjusts the frequency based on the closed-loop feedback for each ultrasonic treatment cycle, taking into account the system resonance of the ultrasonic transducer 506 and the box 800 as an estimated displacement of the resonance point of the ultrasonic transducer 506 due to the effects of pressure / force or temperature on the probe 502 and due to mechanical contact. The frequency can be adjusted for each cycle or for certain cycles.

[0050] A method for determining the maximum power delivery per time period and adjusting the frequency to compensate for the estimated displacement of the resonance point of the ultrasonic transducer 1006 due to the pressure on the probe 502 and the effect of the contact mechanical resonance of the system of the ultrasonic transducer 506 can also be implemented by the probe 502 and the box 800. The driver 508, during each pulse start cycle, defines a set resonance point loop (i.e., continuously calculates an error value based on the difference between the desired set point and the measured process variable, and applies a correction) by scanning a known deviation frequency (i.e., a given frequency that deviates from the center frequency when operating over a period of time) and looking for the maximum power or target power (i.e., power at a specific or predetermined amplitude) through a defined proportional integral derivative (PID) to adjust to the lowest error determined by theoretical calculation based on the LC resonance (i.e., inductor and capacitor) defined by the drive circuit. Loading effects and non-functional transducers are detected by measuring the current at the known resonance point, which can define a non-functional / overloaded ultrasonic transducer. The functional range of current consumption is approximated by measuring the high side current of the drive circuit and based on the statistics of a given sensor.

[0051] In one embodiment, the ultrasonic generator 504 uses a controlled voltage of the ultrasonic transducer 506 to control the total energy delivered to the cartridge 800 containing cells or materials that require lysis or disruption - since uncontrolled actuation may result in over-lysis (i.e., burning) or under-lysis of the sample. The effectiveness of lysis or disruption can be at least partially attributed to the overall mixing of the solution and sample, which is achieved by rapid pulsing of the transducer controlled by electronics using effective pulse width modulation (duty cycle) to control the total power delivered to the ultrasonic transducer 506.

[0052] For example, by including a multilayer piezoelectric element in the ultrasonic generator, the amount of disruption can be increased even at the same frequency and with less power.

[0053] The performance of the external ultrasonic processing system 500 depends on the operation of the external ultrasonic processing system 500 at the resonance point of the external ultrasonic processing system 500. Operating the external ultrasonic processing system 500 at the resonance point can reduce energy loss and heat generation, while operation outside the resonance point can damage the sample or the external ultrasonic processing system 500 due to excessive heat and sound generation. The resonance point is affected by one or more parameters, such as frequency, contact force, surface contact area, and temperature.

[0054] 6A-6B show waveforms of the external ultrasonic processing system 1000. In FIG. 6A-6B, the solid line represents the measured voltage and the dashed line represents the measured current. In FIG. 6A, the external ultrasonic processing system 1000 is not operating at a resonance point - the voltage and current are out of phase. Therefore, the energy transferred is not optimized. In FIG. 6B, the external ultrasonic processing system 1000 is operating at a resonance point - the voltage and current are in phase. Therefore, the energy transferred to the sample is optimized. The y-axis represents amplitude and the x-axis represents time.

[0055] In one embodiment, the resonance point is searched by measuring the current or voltage driving the ultrasonic transducer while sweeping the ultrasonic transducer frequency and voltage. The drive circuit uses the voltage and frequency that produces the measured peak current (resonance point) to deliver the maximum energy to the box with the lowest energy loss.

[0056] In addition, the resonance point can be maintained or changed by preheating the ultrasonic generator 204 by turning on the ultrasonic transducer 206 before the ultrasonic generator 204 contacts the box 800; preloading the contact force of the ultrasonic generator 204 on the box 800 by applying the ultrasonic generator 204 to the box wall before turning on the ultrasonic transducer 206; when the ultrasonic transducer 206 is turned on, the contact force of the ultrasonic generator 204 on the box 800 is pulsed; or, during external ultrasonic treatment, a variable contact force of the ultrasonic generator 204 is used to optimize the transfer of energy to the sample based on the measured ultrasonic transducer energy consumed.

[0057] To measure whether the external ultrasonic processing system is operating within acceptable specifications, changes in voltage, current, temperature, frequency, or a combination thereof may be measured, and thresholds may be set to determine when the system's resonance point deviates from the functional specification settings for each of the above.

[0058] However, it should be noted that switching between operating at the resonance point and operating outside the resonance point may be advantageous. In one aspect, switching between operating at the resonance point and operating outside the resonance point may increase the sample temperature. In another aspect, switching between operating at the resonance point and operating outside the resonance point may mix or agitate the sample without heating or causing destruction of the sample contents.

[0059] 7A-7B show waveforms of undesirable ultrasonic treatment and desired ultrasonic treatment, respectively. In order to determine whether the ultrasonic treatment is desirable or undesirable, the opacity of the sample can be measured before, during and after the ultrasonic treatment. Alternatively, or in addition to the measurements, one or more algorithms can be used to determine the absolute or relative change in the opacity of the sample before and after the ultrasonic treatment, as well as the change in the opacity of the sample during the ultrasonic treatment.

[0060] As shown in Figure 7A, when measuring the change in sample opacity before, during and after external ultrasonic treatment, a small change in voltage (i.e. <30mV) is observed, and very small changes in the signal from the sample are observed during the external ultrasonic treatment. This waveform feature represents an undesirable external ultrasonic treatment of the sample because the opacity change is minimal and the opacity agitation is minimal during the external ultrasonic treatment. The system then uses this information to determine whether additional external ultrasonic treatment should be applied or whether the process should be continued. In the example provided in Figure 7A, additional external ultrasonic treatment will be performed, or a notification of the success or failure of the external ultrasonic treatment will be provided so that the sample will not proceed to the next step at least before the appropriate external ultrasonic treatment occurs. When the external ultrasonic treatment performed provides an undesirable result, the external ultrasonic treatment can be repeated, and the control parameters can be adjusted to achieve the desired result.

[0061] As shown in FIG. 7B , the waveform features represent an ideal external ultrasonic treatment in the sample because there are large changes in opacity and opacity agitation during the ultrasonic treatment. In this example, the system measures the changes that occur in the sample before, during, and after the external ultrasonic treatment. In this example, when measuring the changes in the opacity of the sample before, during, and after the external ultrasonic treatment, a very large voltage change (i.e., >300mV, which is 10 times the change observed in FIG. 7A ) was observed, and a very large signal change from the sample was observed during the external ultrasonic treatment. The system then uses this information to determine whether additional external ultrasonic treatment should be applied or whether testing should continue. In the example provided in FIG. 7B , no additional external ultrasonic treatment is required and the sample can proceed to the next step of testing or processing.

[0062] The ultrasonic processing algorithm can be used to improve the efficiency, effectiveness, or both of an ultrasonic generator (e.g., ultrasonic generator 200). The ultrasonic processing algorithm determines an ultrasonic frequency, such as an optimal ultrasonic frequency, by starting from a first frequency (e.g., 50 kHz) and adjusting the frequency (e.g., by sweeping or increasing) through a given interval (e.g., 200 Hz interval). The ultrasonic processing algorithm also calculates or determines the maximum current (e.g., >500 mA) transmitted from the sample to the ultrasonic generator, which indicates the resonance point.

[0063] The sonotrode may be set to a predetermined frequency to account for system-to-system variability (i.e., variability between sonotrode, between detection systems, between sample readers, between analytical devices or systems, etc.) The variability may be due to differences in one or more cartridges (e.g., due to manufacturing processes), elliptical properties of the sonotrode assembly, the force of the sonotrode head on the cartridge, etc., or a combination thereof.

[0064] The ultrasonic processing algorithm also includes an on / off control to improve ultrasonic processing efficiency while reducing sample damage and box damage. Consider the total time, duration, pause duration, number of pauses, number of pulses, etc., or a combination or compound thereof. In one example, the ultrasonic processing algorithm includes a rest time (e.g., every 25-40 milliseconds) during the active run (e.g., 2-3 seconds) to eliminate local hot spots and prevent cell damage. Longer pause times (e.g., 2-5 seconds) can be used for cooling time. Rest periods (e.g., 25-40 milliseconds) can be used to break fluid collection due to coagulation, surface tension, friction, viscosity, etc., or a combination or compound thereof.

[0065] An example sonication algorithm may be used with reference to a circular ultrasonic generator probe to control energy connection by directing energy to the surface of the cartridge. The sonication algorithm alternates between two operating frequencies (e.g., a primary frequency or a primary frequency and a higher cavitation seeding frequency) and "off" (i.e., no frequency). The sonication algorithm may also switch between a second resonance point at a higher frequency and the nominal resonance frequency so that the higher frequency may cause smaller cavitation bubbles to form or collapse larger bubbles for lysis. The sonication algorithm also operates at a 50% duty cycle to allow the cartridge and sample to remain stationary, thereby dissipating heat and eliminating local hot spots.

[0066] The sonication algorithm may also use lower frequencies, on / off cycles, or both to promote fluid movement to mix at least two substances, including a sample and a solution or reagent.

[0067] FIG. 8A shows an exploded view of an example box 800 for storing and sonicating samples. FIG. 8B shows an isometric view of an example box 800. Box 800 includes a capillary 802 having a capillary plane and a first end and a second end, an O-ring 804, a membrane 806, and a reaction cup 808 having a first end and a second end. Box 800 may also include at least one of a label 810 or a reagent 812. In one embodiment, box 800 may be sealed. For example, box 800 is sealed to the external environment. In another example, the box may be permanently or temporarily sealed.

[0068] The capillary 802 draws the blood sample into the box 800 by capillary action, or captures a fixed volume of sample from a drop of blood. When the capillary 802 and the reaction cup 808 are adjacent, such as during the locking process or the snapping process, the capillary plane of the capillary 802 pierces the membrane 806 of the reaction cup 808. The capillary 802 may include a capillary coating 814 to enhance the wicking of the sample through the capillary 802. In one embodiment, the sample can be added directly to the reaction cup 808 by pipetting, pouring, etc. The sample may include one or more reagents, one or more ultrasonic particles, or one or more reagents and one or more ultrasonic particles.

[0069] In one embodiment, the capillary 802 and the reaction cup 808 are integral. In one embodiment, the capillary 802 and the reaction cup 808 are separate components. For example, the reaction cup 808 is locked to one or more other components of the box 800. In addition, the capillary 802 is locked to one or more other components of the box 800, for example. Alternatively, the reaction cup 808 and the capillary 802 can be snapped together, and once snapped together, they will not separate. Although the box 800 is discussed as including the capillary 802, the box 800 can be formed without the capillary 802, or another mechanism is used to obtain or transfer the material or diluent into the reaction cup 808.

[0070] The cuvette 808 is composed of one or more materials, such as glass, crystal, plastic, or a combination thereof, whose optical properties allow light from a light source to pass through the cuvette 808 into the sample to collect information about the sample. For example, the cuvette 808 can be optically transparent to allow imaging or data collection. In another example, the cuvette 808 can be transparent, semi-transparent, or translucent. In yet another example, the material can be selected based on a specific wavelength to be filtered out or to be passed to the sample.

[0071] The first end of the reaction cup 808 may include a membrane 806. The membrane 806 seals the reagent 812 in the reaction cup 808 to prevent spillage, for storage purposes, to contain the sample during external sonication, or for later use. The seal of the membrane 806 may be formed by a hot stake with a mandrel, a hot stake with a precise volume, a hot stake with excess reagent in the reaction cup 808, a cold-hot stake with excess reagent in the reaction cup 808, or other methods of sealing the fluid in the reaction cup 808. In addition, the membrane 806 may include a hydrophilic coating that changes the shape of the meniscus of the reagent 812 during the hot melt process.

[0072] The second end of the reaction cup 808 may include a fluid chamber for accommodating reagents 812, samples, or a combination thereof. The reaction cup 808 may also include a given volume of reagents 812 or samples. Reagents may include, but are not limited to, deionized water, surfactants, defoamers, colorants (e.g., fluorescent, coloring, etc.), etc. In one embodiment, 2% Triton (i.e., a surfactant; a nonionic surfactant having a hydrophilic polyethylene oxide chain and an aromatic hydrocarbon lipophilic or hydrophobic group) is used as a reagent (e.g., for optimizing external ultrasonic treatment), a capillary coating (e.g., for enhancing sample collection and wicking), and for releasing hemochromic pigments when needed. In another embodiment, a variety of reagents may be used. For example, surfactants and colorants may be used.

[0073] In one embodiment, the reaction cup 808 may also include at least one ultrasonic treatment particle for increasing mixing, enhancing ultrasonic treatment, or increasing mixing and enhancing ultrasonic treatment. The at least one ultrasonic treatment particle may be composed of glass, polymer, metal, silicon dioxide, a combination thereof, etc. For example, 16 glass beads are added to a sample (e.g., blood) to increase mixing and enhance ultrasonic action. In one embodiment, when two or more ultrasonic treatment particles are included, no two ultrasonic treatment particles are composed of the same material, so that at least one ultrasonic treatment particle is composed of a first material, and at least one ultrasonic treatment particle is composed of a second material. In another embodiment, when two or more ultrasonic treatment particles are included, all ultrasonic treatment particles are composed of the same material, so that two or more ultrasonic treatment particles are composed of a first material. Alternatively, before at least one ultrasonic treatment particle is added to the reaction cup 808, it may be added to the sample.

[0074] The O-ring 804, which may be located on the capillary 802 or the cuvette 808, provides a seal between the capillary 802 and the cuvette 808 when the capillary 802 and the cuvette 808 are locked or snapped together. The seal provided by the O-ring 804 may be fluid and air tight.

[0075] The thickness and shape of the wall of the box 800 are two parameters that affect the transmission of ultrasonic energy. Therefore, the optimal wall thickness and wall shape can enhance the ultrasonic energy transmission or make the ultrasonic energy transmission more effective. In addition, the ultrasonic probe 1404 is designed to enhance the ultrasonic energy transmission based on the material type of the box 800, the wall thickness of the box 800, the wall shape of the box 800, or a combination thereof.

[0076] The label 810 includes a control number that can be encoded as a second number by an encryption algorithm. At least one batch number, revision number, or serial number (whether in whole or in part) can be encrypted. The control number can also include a manufacturing date to prevent use after the expiration date. The label 810 can also include a design, such as a graphic, code (e.g., a QR code), or image, which can be visible to the human eye or only visible to a machine or through another visualization system. The design can include encrypted data.

[0077] In one embodiment, one or more machines do not work (e.g., external ultrasonic processing system 1100 or reader 100, 140) when the encrypted number is incorrect (i.e., the encrypted number does not fit the required or correct format, or does not correspond to the unencrypted number), has been used, or is not found in the lookup table. This prevents the reuse of box 800 or the use of unauthenticated boxes. One or more machines record each box used, such as recording on internal memory, and upload the serial number to a server or table, which can be internal to the computer or remotely connected, such as in the cloud. When connected to the cloud or remote server, the used serial numbers can be downloaded to all machines to prevent reuse in different computers, or to prevent the use of duplicate tags or serial numbers. Optionally, the remote server can receive all used serial numbers and identify those that have been used multiple times (including twice or more). The remote server can compare the serial number with a database or lookup table. Devices that have been used more than once (e.g., two or more times) may be automatically pushed to one or more machines based on the location of the machine, how often the machine has been used, proximity to attempted counterfeit use on other machines, etc. An application, such as one loaded onto the machine or stored in the cloud, may be used to check the data for duplicate serial numbers and flag them for review, such as by a human or another application.

[0078] As another way to prevent reuse, the label 810 or another portion of the box 800 can include at least one of the electrical fuse connections. As yet another way to prevent reuse, the label 810 or another portion of the box 800 can be marked, scratched, changed in color, physically changed (e.g., dented, pop-up, etc.) or a combination thereof.

[0079] An electronic tag (eg, an IC tag) or a radio frequency identification (RFID) tag may be included on the label 810 or another portion of the box 800 .

[0080] The custom designed cartridge used in conjunction with the second device is locked into the second device so that all degrees of freedom are restricted to reduce the chance of vibration or sloshing of the fluid sample / media, allowing for lower noise and higher sensitivity measurements of sample volume.

[0081] Fig. 8 C shows the cross-sectional view of the box 800 intercepted along line II.Box 800 includes an ultrasonic chamber 820, in which a sample is added or positioned to carry out ultrasonic treatment.The ultrasonic treatment chamber 820 may include ultrasonic treatment particles 830, as shown in the enlarged view 822.The ultrasonic treatment particles 830 improve or enhance ultrasonic treatment, sample mixing or both.Can use any number of ultrasonic treatment particles 830 (for example, up to 1000, including 20-30), and the ultrasonic treatment particles 830 can be any suitable size (for example, up to 10mm, including 0.6mm, 1mm etc.).

[0082] When sonication is stopped, the density or size of the sonicated particles 830 can drop to the bottom of the sample. The sonicated particles 830 can mechanically lyse sample components by the movement of the sonicated particles 830, the formation of seeded cavitation bubbles, or both.

[0083] In one example, the ultrasonic particles 830 provide an increased surface area where cavitation can occur (i.e., a seeding point for cavitation). During the ultrasonic treatment process, cavitation may occur, thereby forming bubbles within the sample. The bubbles with energy (e.g., kinetic energy) can agitate or disrupt sample components (i.e., break membranes, vacuoles, etc.). In another example, the ultrasonically agitated ultrasonic particles 830 can move within the sample. The ultrasonic particles 830 contact the sample components and agitate or disrupt the sample components (i.e., break membranes, vacuoles, etc.).

[0084] In one example, the ultrasonic particles 830 can be added to the ultrasonic treatment chamber 820 before adding the sample. The ultrasonic particles 830 are adhered to the inner wall of the ultrasonic treatment chamber 830, for example by coating the ultrasonic particles 830 in an adhesive or viscous solution (e.g., Triton solution) before adding to the ultrasonic treatment chamber 830. When dried, the ultrasonic particles 830 retain a sticky residue. The ultrasonic particles 830 can be removed from the box 800 before using one or more reagents or ultrasonic treatment by the sample itself. The reagent or solution can decompose the sample components by itself.

[0085] In another example, the sonication particles 830 can be added to the sample before adding the sample to the cartridge 800 .

[0086] Examples of adhering the sonicated particles 830 to the ultrasonic chamber 820 include adding the sonicated particles 830 to the ultrasonic chamber 820, adding a reagent (e.g., 2 μL of 2% Triton), and drying (e.g., air drying, curing, or heat drying). The sonicated particles 830 are then coated in a residue that adheres the sonicated particles 830 to the inner wall of the ultrasonic chamber 820.

[0087] The cartridge 800 may also include cavitation seeders, such as cutouts, ridges, braided wires, etc., or a combination or composite thereof, to seed cavitation. The cartridge 800 may include a cavitation seeder and ultrasonic treatment particles 830.

[0088] Although certain elements, aspects, components, etc. are described with respect to one embodiment or example (e.g., an exemplary external ultrasonic processing system), these elements, aspects, components, etc. may be included in any other external ultrasonic processing system, such as when it is desired or advantageous to do so.

[0089] For the purpose of explanation, the above description uses specific terms to provide a thorough understanding of the present disclosure. However, it will be apparent to those skilled in the art that specific details are not required in order to implement the systems and methods described herein. For the purpose of illustration and description, the foregoing descriptions of specific embodiments are presented by way of example. They are not intended to be exhaustive or to limit the present disclosure to the precise form described. In view of the above teachings, many modifications and variations are possible. The embodiments are shown and described in order to best explain the principles and practical applications of the present disclosure, so that other technical personnel in the art can best utilize the present invention and various embodiments with various modifications suitable for the intended specific use. The scope of the present disclosure is defined by the following claims and their equivalents.

Claims

1. An external ultrasonic processing system for ultrasonically processing a patient sample stored in a patient sample box, the patient sample box having an outer wall, the system comprising: an external ultrasonic generator including an ultrasonic transducer connected to a probe, wherein when the probe contacts an outer wall of the patient sample cartridge, a probe contact force is generated between the probe and the outer wall of the patient sample cartridge; and A microcontroller electrically connected to the external ultrasonic generator, the microcontroller being configured as: Generate signals to control characteristics or parameters of ultrasonic transducers, transmits the signal to the ultrasonic transducer, and The ultrasound transducer is caused to generate ultrasound energy according to the characteristic or parameter, and the generated ultrasound energy is transmitted through the outer wall of the patient sample cartridge based on the probe contact force between the probe and the outer wall of the patient sample cartridge.

2. The system of claim 1, wherein the probe comprises a shape that conforms to the contour of an outer wall of the patient sample cartridge.

3. The system of claim 1, wherein the probe comprises a cutout, an opening, or a shape that conforms to the contour of an outer wall of the patient sample cartridge.

4. The system of claim 1, wherein the ultrasound transducer is connected to the probe at an undamped or non-resonant point to change the pressure or force.

5. The system of claim 1, wherein the probe comprises a length proportional to or matched to a resonant frequency of the ultrasound transducer.

6. The system of claim 1, wherein the external sonotrode is configured to be oriented in one of a plurality of directions.

7. The system of claim 1 , wherein the microcontroller is programmed to control a characteristic or parameter of the ultrasonic transducer based on at least one of a position of the external ultrasonic generator relative to an outer wall of the patient sample box, a contact pressure of the probe relative to an outer wall of the patient sample box, sample sonication feedback, user input settings, and manufacturing component feedback.

8. The system of claim 7, wherein the control is fixed or variable.

9. The system of claim 1, wherein the characteristics or parameters include ultrasonic energy transfer efficiency, fixed or variable frequency, on or off ultrasonic generator probe resonance point, temperature, applied voltage, current, voltage on / off time, current on / off time, or a combination or composite thereof.

10. The system of claim 1, wherein the microcontroller is further configured to determine a resonant point drift outside of a functional frequency by measuring changes in current, voltage, frequency, temperature, or a combination thereof.

11. The system of claim 1, wherein the microcontroller is further configured to control the position and contact force of the external ultrasonic generator relative to an outer wall of the patient sample cartridge.

12. The system of claim 1, wherein the microcontroller is further configured to initiate transfer of the ultrasonic energy into the patient sample cartridge by varying a voltage or current applied to the ultrasonic transducer at a fixed or random frequency close to a resonance point of the ultrasonic transducer.

13. The system of claim 1, wherein the microcontroller is further configured to decrease or increase a voltage or current applied to the ultrasonic transducer.

14. The system of claim 1, wherein the microcontroller is further configured to pulse the voltage or current applied to the ultrasonic transducer.

15. The system of claim 1, wherein the microcontroller is further configured to: When the temperature of the ultrasonic transducer exceeds a thermal threshold, turning off the voltage or current applied to the ultrasonic transducer; and When the temperature of the ultrasound transducer reaches a cooling threshold, the voltage or current is turned on.

16. The system of claim 1, wherein the microcontroller is further configured to search for a resonance point of the ultrasonic transducer by measuring a current and a voltage driving the ultrasonic transducer when measuring the frequency of the ultrasonic transducer.

17. The system of claim 1, wherein the microcontroller is further configured to: Turning on the ultrasonic transducer before the external ultrasonic generator contacts the outer wall of the patient sample box, thereby preheating the external ultrasonic generator, and turning off the ultrasonic transducer after preheating; Before turning on the ultrasonic transducer, preloading the contact force of the external ultrasonic transducer by applying the probe of the external ultrasonic generator to the outer wall of the patient sample box; When the ultrasonic transducer is turned on, the contact force of the external ultrasonic generator is pulsed; Varying the contact force of an external sonotrode; or A combination or compound thereof.

18. The system of claim 1, wherein the microcontroller is further configured to switch between turning on a resonance point of the ultrasound transducer and turning off a resonance point of the ultrasound transducer to mix or agitate the patient sample without heating or causing damage to the patient sample, or increasing the sample temperature.

19. The system of claim 1, wherein the microcontroller is further configured to: The opacity of the sample before sonication was measured and compared with a threshold value; The sample opacity during sonication is measured and compared to a threshold value; The opacity of the sample after sonication was measured and compared with a threshold value; configuring one or more algorithms to determine an absolute or relative change in opacity of the sample before and after sonication and using the change in opacity of the sample during sonication; or A combination or compound thereof.

20. The system of claim 1, wherein the microcontroller is configured to: Repeat the ultrasound at least once; Adjust control parameters; Fault notifications that result in output sonication; resulting in the output of a successful sonication notification; or A combination or compound thereof.

21. The system of claim 1, wherein the microcontroller is further configured to determine the resonance point drift outside of the functional specification by: Measure changes in voltage, current, temperature, and frequency; and Compare voltage, current, temperature, and frequency change measurements to threshold values.

22. The system of claim 1, wherein: The microcontroller is also configured to determine a maximum power delivery per time period and adjust the frequency to compensate for an estimated displacement of the resonance point of the ultrasound transducer due to the effects of pressure or temperature on the probe and contact mechanical resonance of the outer wall of the patient sample box.

23. The system of claim 22, wherein the microcontroller is further programmed to test for a known deviation frequency at the beginning of each pulse cycle and determine a maximum or target power delivery via a defined proportional-integral-derivative (PID) loop to adjust for minimum error based on the inductor-capacitor resonance of the drive circuit.

24. The system of claim 22, wherein the microcontroller is further programmed to identify a non-functioning or overloaded ultrasonic transducer by measuring a high side current of a driver circuit and comparing the high side current to statistical data of the ultrasonic transducer, wherein the statistical data includes a functional range of current consumption at one or more known resonant frequencies.